Cited In for PMID: 21811258

Year	Number of Results
2011	1
2012	4
2013	6
2014	4
2015	2
2016	4
2017	6
2018	5
2020	4
2021	1
2022	3
2023	1
2024	1
2025	3
2026	1

1

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction.

Wainberg ZA, Lin LS, DiCarlo B, Dao KM, Patel R, Park DJ, Wang HJ, Elashoff R, Ryba N, Hecht JR. Wainberg ZA, et al. Br J Cancer. 2011 Sep 6;105(6):760-5. doi: 10.1038/bjc.2011.280. Epub 2011 Aug 2. Br J Cancer. 2011. PMID: 21811258 Free PMC article. Clinical Trial.

2

First-line maintenance strategies and later-line options in patients with advanced gastroesophageal adenocarcinoma.

Marchesi S, Sciortino C, Etessami J, Damonte C, Villa C, Bottelli A, Alessandrini S, Chiaramonte A, Sabella G, Pietrantonio F, Morano F, Randon G. Marchesi S, et al. Ther Adv Med Oncol. 2025 Dec 26;17:17588359251389741. doi: 10.1177/17588359251389741. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 41472945 Free PMC article. Review.

3

The biology and therapeutic implications of heterogeneity in Barrett oesophagus and oesophageal adenocarcinoma.

McClurg DP, Pan S, Fitzgerald RC, Jones CM. McClurg DP, et al. Nat Rev Clin Oncol. 2026 Jan;23(1):40-62. doi: 10.1038/s41571-025-01084-0. Epub 2025 Nov 11. Nat Rev Clin Oncol. 2026. PMID: 41219393 Review.

4

Current Landscape of Molecular Biomarkers in Gastroesophageal Tumors and Potential Strategies for Co-Expression Patterns.

Korpan M, Puhr HC, Berger JM, Friedrich A, Prager GW, Preusser M, Ilhan-Mutlu A. Korpan M, et al. Cancers (Basel). 2025 Jan 21;17(3):340. doi: 10.3390/cancers17030340. Cancers (Basel). 2025. PMID: 39941712 Free PMC article. Review.

5

EGFR mutations and abnormal trafficking in cancers.

Kang X, Li R, Li X, Xu X. Kang X, et al. Mol Biol Rep. 2024 Aug 21;51(1):924. doi: 10.1007/s11033-024-09865-z. Mol Biol Rep. 2024. PMID: 39167290 Review.

6

Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update.

Naik RR, Shakya AK. Naik RR, et al. Front Pharmacol. 2023 Jan 9;13:1064472. doi: 10.3389/fphar.2022.1064472. eCollection 2022. Front Pharmacol. 2023. PMID: 36699049 Free PMC article. Review.

7

Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer.

Haque E, Esmail A, Muhsen I, Salah H, Abdelrahim M. Haque E, et al. Cancers (Basel). 2022 Nov 15;14(22):5615. doi: 10.3390/cancers14225615. Cancers (Basel). 2022. PMID: 36428707 Free PMC article. Review.

8

Toward Targeted Therapies in Oesophageal Cancers: An Overview.

Bregni G, Beck B. Bregni G, et al. Cancers (Basel). 2022 Mar 16;14(6):1522. doi: 10.3390/cancers14061522. Cancers (Basel). 2022. PMID: 35326673 Free PMC article. Review.

9

Cell cycle arrest and apoptosis induction by Juniperus communis extract in esophageal squamous cell carcinoma through activation of p53-induced apoptosis pathway.

Li CY, Lee SC, Lai WL, Chang KF, Huang XF, Hung PY, Lee CP, Hsieh MC, Tsai NM. Li CY, et al. Food Sci Nutr. 2020 Dec 30;9(2):1088-1098. doi: 10.1002/fsn3.2084. eCollection 2021 Feb. Food Sci Nutr. 2020. PMID: 33598192 Free PMC article.

10

Targeting EGFR in Esophagogastric Cancer.

Maron SB, Xu J, Janjigian YY. Maron SB, et al. Front Oncol. 2020 Dec 8;10:553876. doi: 10.3389/fonc.2020.553876. eCollection 2020. Front Oncol. 2020. PMID: 33364187 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 21811258

39 results

Results by year